Dr Reddy's Laboratories Receivables 2010-2024 | RDY

Dr Reddy's Laboratories receivables for the quarter ending June 30, 2024 were $0.973B, a 3.62% increase year-over-year.

  • Dr Reddy's Laboratories receivables for 2024 were $0.963B, a 9.18% increase from 2023.
  • Dr Reddy's Laboratories receivables for 2023 were $0.882B, a 0.23% increase from 2022.
  • Dr Reddy's Laboratories receivables for 2022 were $0.88B, a 29.6% increase from 2021.

Dr Reddy's Laboratories Receivables 2010-2024 | RDY

  • Dr Reddy's Laboratories receivables for 2024 were $0.963B, a 9.18% increase from 2023.
  • Dr Reddy's Laboratories receivables for 2023 were $0.882B, a 0.23% increase from 2022.
  • Dr Reddy's Laboratories receivables for 2022 were $0.88B, a 29.6% increase from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$20.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M